Case Study: Global Pharmaceutical Company reduces discovery costs with Epiq's dual-shore review teams

Global Pharmaceutical Company Reduces Discovery Costs With Dual-Shore Review Teams

The global pharmaceutical company faced the challenge of managing the high costs and complexity of a Hatch-Waxman patent litigation matter. To engage skilled reviewers while balancing the budget, they turned to Epiq for a document review solution.

Epiq implemented a hybrid, dual-shore review model. They used a team in India for the first-level review and initial QC, while a specialized U.S.-based team handled highly technical documents and final QC. This strategy resulted in the review of 260,000 documents and allowed Epiq to complete the first-level review ahead of schedule, achieving a 35% cost savings for the client compared to a U.S.-only approach.